[1]

[2]

SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120.

[3]

LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129.

[4]

YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140.

[5]

XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146.

[6]

CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152.

[7]

. [J]. Laboratory Medicine, 2023, 38(12): 1153-1156.

[8]

. [J]. Laboratory Medicine, 2023, 38(12): 1157-1159.

[9]

[10]

YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172.

[11]

DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176.

[12]

GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182.

[13]

. [J]. Laboratory Medicine, 2023, 38(12): 1183-1185.

[14]

. [J]. Laboratory Medicine, 2023, 38(12): 1186-1190.

[15]

. [J]. Laboratory Medicine, 2023, 38(12): 1191-1194.

项目	颗粒浓度（个/μL）	比对样本数（例）	407标准不合格数（例）	407标准符合率（%）	泊松标准不合格数（例）	泊松标准符合率（%）	95%符合率标准误（%）	可接受符合率下限（%）
RBC	1.1~44.8	68	6	91.2	5	92.6	2.64	89.8
WBC	1.5~46.2	61	0	100.0	0	100.0	2.79	89.5
CAST	0.0~32.7	110	12	89.1	10	90.9	2.08	90.9
EC	1.4~37.6	86	5	94.2	6	93.0	2.35	90.4
BACT	2.7~48.0	25	1	96.0	6	76.0	4.36	86.5

项目	颗粒浓度（个/μL）	比对样本数（例）	407标准不合格数（例）	407标准符合率（%）	泊松标准不合格数（例）	泊松标准符合率（%）	95%符合率标准误（%）	可接受符合率下限（%）
RBC	1.1~44.8	68	6	91.2	5	92.6	2.64	89.8
WBC	1.5~46.2	61	0	100.0	0	100.0	2.79	89.5
CAST	0.0~32.7	110	12	89.1	10	90.9	2.08	90.9
EC	1.4~37.6	86	5	94.2	6	93.0	2.35	90.4
BACT	2.7~48.0	25	1	96.0	6	76.0	4.36	86.5

RichHTML

PDF (PC)

[1]	SYSMEX公司. 全自动尿有形成分分析仪UF-1000i操作手册[M]. 神户:SYSMEX公司,2008:10-12.
[2]	WS/T 407—2012 医疗机构内定量检验结果的可比性验证指南[S]. 北京:中华人民共和国卫生行业标准,2012.
[3]	Clinical and Laboratory Standards Institute. Expression of measurement uncertainty in laboratory medicine[S]. C51-A,CLSI,2012.
[4]	SHAPIRO H M.Practical flow cytometry[M]. 4th ed. New Jersey:John Wiley and Sons,Inc.,2003:19.
[5]	颜虹. 医学统计学[M]. 7版. 北京:人民卫生出版社,2012:499.